Social
In Israel (as of Feb 2021) 84% of those ≥70 years and 10% for <50 years have received 2 doses of the COVID Vaccine; as such the need for mechanical ventilation in the elderly has declined 67% with the implementation of COVID vaccines. https://t.co/9Qnv72QYUS
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
My Experience as a COVID19 Vaccine Trial Participant
https://t.co/ILfXLUL8IZ
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Email Survey study of HSS rheumatic pts 7,094 responded 1,547 were women (18-50yrs) & 61 (4%) were pregnant during COVID. COVID prevalence was similar in PREG vs nonPREG (8% vs.9% ), PREG COVID pts had shorter Sxs, more loss taste/smell. https://t.co/4HDuXbZVrs
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Common mucocutaneous findings in 35 kids w/ MIS-C & COVID: 1) conjunctival injection (21), palmoplantar erythema (18), lip hyperemia (17), periorbital erythema/edema (7), strawberry tongue (8), & malar erythema (6) https://t.co/mcSOXtXaEh
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
Could the PEG portion be responsible for IgE and non-IgE mediated COVID vaccine reactions? Both Moderna and Pfizer use the same 2000kd PEG for stability of the lipid nanoparticle. (Recall Miralax and PEG reactions...) Dr. A Postolova #RWCS2021 #RWCS @RWCSmtg @RheumNow https://t.co/ALXvR2h21z
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 3 months ago
Vaccinated COVID-19 pts appear less contagious; report from Israel - among 650,000 received two-doses of Pfizer vaccine, 2,897 later tested positive for COVID-19, but nasal swab samples showed 4-fold less virus - hinting protection https://t.co/UBE4q6aE63
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
ACR Promotes New COVID-19 Vaccine Clinical Guidance for Rheumatic Patients
The ACR has published a draft guidance on the use of COVID-19 vaccination in RMD patients, based on the efforts of the North American Task Force.
https://t.co/uSPfvJB8EC https://t.co/9bwBdtHw5e
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
Preprint from UK trial shows tocilizumab efficacy in COVID-19. 2022 TCZ vs 2094 usual care pts (also on dexamethasone), in hospitalized pts on ventilators. 28 day mortality was 29% on TCZ Vs 33% with usual care - TCZ had 23% incr probability of discharge https://t.co/Curd6W20qK https://t.co/0TbhJYh5vM
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
Comorbidity and Drugs Drive COVID-19 Severity and Survival in Rheumatic Disease
While comorbidities are associated with severe COVID-19 infection, it appears they also influence severity and survival in RMD according to a French cohort study.
https://t.co/8rh1YvtqoE https://t.co/dxVGkdTPKg
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
Congrats to ACR Task Force who published guidelines on RMD drug use w/ COVID vaccines. My views on their recs:
1. I agree, no change most DMARD, biologics
2. I disagree; I would NOT hold Orencia, I would NOT hold JAKi
3. I disagree: I would not hold MTX https://t.co/uSPfvJB8EC https://t.co/SznUJosmpo
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
